286 related articles for article (PubMed ID: 11457475)
21. Complement Receptor 2 Based Immunoassay Measuring Activation of the Complement System at C3-Level in Plasma Samples From Mice and Humans.
Halkjær L; Troldborg A; Pedersen H; Jensen L; Hansen AG; Hansen TK; Bjerre M; Østergaard JA; Thiel S
Front Immunol; 2020; 11():774. PubMed ID: 32431705
[TBL] [Abstract][Full Text] [Related]
22. C3b2-IgG complexes retain dimeric C3 fragments at all levels of inactivation.
Jelezarova E; Luginbuehl A; Lutz HU
J Biol Chem; 2003 Dec; 278(51):51806-12. PubMed ID: 14527961
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of C3 and IgG proteolysis enhances phagocytosis of Porphyromonas gingivalis.
Cutler CW; Arnold RR; Schenkein HA
J Immunol; 1993 Dec; 151(12):7016-29. PubMed ID: 8258706
[TBL] [Abstract][Full Text] [Related]
24. Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.
Verbrugh HA; Van Dijk WC; Peters R; Van Der Tol ME; Peterson PK; Verhoef J
Immunology; 1979 Mar; 36(3):391-7. PubMed ID: 108204
[TBL] [Abstract][Full Text] [Related]
25. Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera.
Håkansson L; Hällgren R; Venge P
Immunology; 1982 Sep; 47(1):91-9. PubMed ID: 6981589
[TBL] [Abstract][Full Text] [Related]
26. Cleavage of complement C3b to iC3b on the surface of Staphylococcus aureus is mediated by serum complement factor I.
Cunnion KM; Hair PS; Buescher ES
Infect Immun; 2004 May; 72(5):2858-63. PubMed ID: 15102797
[TBL] [Abstract][Full Text] [Related]
27. The biochemistry of opsonization: central role of the reactive thiolester of the third component of complement.
Hostetter MK; Krueger RA; Schmeling DJ
J Infect Dis; 1984 Nov; 150(5):653-61. PubMed ID: 6491376
[TBL] [Abstract][Full Text] [Related]
28. Macrophage complement receptors and pathogen clearance.
van Lookeren Campagne M; Wiesmann C; Brown EJ
Cell Microbiol; 2007 Sep; 9(9):2095-102. PubMed ID: 17590164
[TBL] [Abstract][Full Text] [Related]
29. Differences in the ingestion mechanisms of IgG and C3b particles in phagocytosis by neutrophils.
Hed J; Stendahl O
Immunology; 1982 Apr; 45(4):727-36. PubMed ID: 6279489
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of complement activation and opsonophagocytosis by complexes of mannose-binding lectin with mannose-binding lectin-associated serine protease after binding to Staphylococcus aureus.
Neth O; Jack DL; Johnson M; Klein NJ; Turner MW
J Immunol; 2002 Oct; 169(8):4430-6. PubMed ID: 12370377
[TBL] [Abstract][Full Text] [Related]
31. Mannose-binding lectin (MBL) facilitates opsonophagocytosis of yeasts but not of bacteria despite MBL binding.
Brouwer N; Dolman KM; van Houdt M; Sta M; Roos D; Kuijpers TW
J Immunol; 2008 Mar; 180(6):4124-32. PubMed ID: 18322223
[TBL] [Abstract][Full Text] [Related]
32. Suboptimal C3b/C3bi deposition and defective yeast opsonization. II. Partial purification and preliminary characterization of an opsonic co-factor able to correct sera with the defect.
Turner MW; Seymour ND; Kazatchkine MD; Mowbray JF
Clin Exp Immunol; 1985 Nov; 62(2):435-41. PubMed ID: 3910314
[TBL] [Abstract][Full Text] [Related]
33. The role of membrane receptors for C3b and C3d in phagocytosis.
Ehlenberger AG; Nussenzweig V
J Exp Med; 1977 Feb; 145(2):357-71. PubMed ID: 833545
[TBL] [Abstract][Full Text] [Related]
34. Serum opsonization capacity, phagocytosis, and oxidative burst activity in neonatal foals in the intensive care unit.
Gardner RB; Nydam DV; Luna JA; Bicalho ML; Matychak MB; Flaminio MJ
J Vet Intern Med; 2007; 21(4):797-805. PubMed ID: 17708402
[TBL] [Abstract][Full Text] [Related]
35. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of C3b/C3bi opsonization and chemiluminescence with selected yeasts and bacteria using sera of different opsonic potential.
Turner MW; Grant C; Seymour ND; Harvey B; Levinsky RJ
Immunology; 1986 May; 58(1):111-5. PubMed ID: 3519441
[TBL] [Abstract][Full Text] [Related]
37. The attachment of serum- and plasma-derived C3 to solid-phase immune aggregates and its relation to complement-mediated solubilization of immune complexes.
Baatrup G; Svehag SE; Jensenius JC
Scand J Immunol; 1986 Apr; 23(4):397-406. PubMed ID: 3486458
[TBL] [Abstract][Full Text] [Related]
38. Neutrophil function and plasma opsonic capacity in colostrum-fed and colostrum-deprived neonatal kittens.
Hanel RM; Crawford PC; Hernandez J; Benson NA; Levy JK
Am J Vet Res; 2003 May; 64(5):538-43. PubMed ID: 12755291
[TBL] [Abstract][Full Text] [Related]
39. The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.
Gadd KJ; Reid KB
Biochem J; 1981 May; 195(2):471-80. PubMed ID: 7316962
[TBL] [Abstract][Full Text] [Related]
40. Yeast opsonization and phagocytosis studied by a visual assay and measurement of neutrophil chemiluminescence.
Vernon J; Kemp AS; Van Asperen PP; Worsdall P; Roy LP
J Clin Lab Immunol; 1984 Jun; 14(2):93-7. PubMed ID: 6748051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
